These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24306133)

  • 1. Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience.
    Trotti LM; Saini P; Freeman AA; Bliwise DL; García PS; Jenkins A; Rye DB
    J Psychopharmacol; 2014 Jul; 28(7):697-702. PubMed ID: 24306133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medications for daytime sleepiness in individuals with idiopathic hypersomnia.
    Trotti LM; Becker LA; Friederich Murray C; Hoque R
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012714. PubMed ID: 34031871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial.
    Trotti LM; Saini P; Bliwise DL; Freeman AA; Jenkins A; Rye DB
    Ann Neurol; 2015 Sep; 78(3):454-65. PubMed ID: 26094838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Medicine for Idiopathic Hypersomnia.
    Arnulf I; Leu-Semenescu S; Dodet P
    Sleep Med Clin; 2019 Sep; 14(3):333-350. PubMed ID: 31375202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic Hypersomnia and Other Hypersomnia Syndromes.
    Trotti LM; Arnulf I
    Neurotherapeutics; 2021 Jan; 18(1):20-31. PubMed ID: 32901432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
    Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
    Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Perception and Attention Functions test battery as a measure of neurocognitive impairment in patients with suspected central disorders of hypersomnolence.
    Ramm M; Jafarpour A; Boentert M; Lojewsky N; Young P; Heidbreder A
    J Sleep Res; 2018 Apr; 27(2):273-280. PubMed ID: 28771870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on hypersomnias of central origin.
    Drakatos P; Leschziner GD
    Curr Opin Pulm Med; 2014 Nov; 20(6):572-80. PubMed ID: 25165990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions.
    Dauvilliers Y; Delallée N; Jaussent I; Scholz S; Bayard S; Croyal M; Schwartz JC; Robert P
    Sleep; 2012 Oct; 35(10):1359-66. PubMed ID: 23024434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors.
    Rye DB; Bliwise DL; Parker K; Trotti LM; Saini P; Fairley J; Freeman A; Garcia PS; Owens MJ; Ritchie JC; Jenkins A
    Sci Transl Med; 2012 Nov; 4(161):161ra151. PubMed ID: 23175709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychomotor vigilance task demonstrates impaired vigilance in disorders with excessive daytime sleepiness.
    Thomann J; Baumann CR; Landolt HP; Werth E
    J Clin Sleep Med; 2014 Sep; 10(9):1019-24. PubMed ID: 25142762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of armodafinil on objective sleepiness and performance in a shift work disorder sample unselected for objective sleepiness.
    Howard R; Roth T; Drake CL
    J Clin Psychopharmacol; 2014 Jun; 34(3):369-73. PubMed ID: 24717254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical spectrum of narcolepsy and idiopathic hypersomnia.
    Aldrich MS
    Neurology; 1996 Feb; 46(2):393-401. PubMed ID: 8614501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical neurophysiology of CNS hypersomnias.
    Barateau L; Lopez R; Dauvilliers Y
    Handb Clin Neurol; 2019; 161():353-367. PubMed ID: 31307613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From wakefulness to excessive sleepiness: what we know and still need to know.
    Ohayon MM
    Sleep Med Rev; 2008 Apr; 12(2):129-41. PubMed ID: 18342261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanin concentrating hormone in central hypersomnia.
    Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
    Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypersomnia: a diagnostic problem].
    Kranenburg G; Teunissen LL
    Ned Tijdschr Geneeskd; 2014; 158():A7537. PubMed ID: 25096034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.